interrogate mutational hotspots in 67 genes (51.5 kb in total) in 276 biopsies of testes from 5 48 men (median age: 83 years). Following ultra-deep sequencing (~16,000x), development of a 49 low-frequency variant prioritization strategy and targeted validation, we identified 61 distinct 50 variants present at frequencies as low as 0.06%, including 54 variants not previously directly 51 associated with selfish selection. The majority (80%) of variants identified have previously 52 been implicated in developmental disorders and/or oncogenesis and include mutations in six 53 newly associated genes (BRAF, CBL, MAP2K1, MAP2K2, RAF1 and SOS1), all of which encode 54 components of RAS-MAPK pathway and activate signaling. Our findings extend the link 55 between mutations dysregulating the RAS-MAPK pathway and selfish selection, and show 56 that the ageing male germline is a repository for such deleterious mutations. 57
INTRODUCTION 58
The timing, location and functional effects of spontaneous mutations determine the 59 distribution and phenotypes of mutant cells within the body: this can have a variety of impacts 60 on the health of an individual, and potentially, their offspring. Spontaneous mutations 61 occurring during early post-zygotic development lead to widespread tissue mosaicism that, 62 depending on context, may be phenotypically undetectable or cause so-called 'somatic' 63 disorders (Campbell et al. 2015) . Such early post-zygotic mosaicism occurs commonly, with 64 up to 22% of apparently de novo point mutations (DNMs) detectable in a child's blood sample 65 likely to have occurred after fertilization (Acuna-Hidalgo et al. 2015; Krupp et al. 2017) . A 66 corollary is that a further ~4-10% of DNMs and ~4% of copy-number variants (CNVs) present 67 in a child can be detected at low-level in one of the parent's somatic (usually blood or saliva) 68 samples, and are therefore in fact inherited; as these would have occurred early during 69 parental post-zygotic development (before the separation of the somatic and gonadal 70 lineages), they are associated with a significant risk of recurrence (Campbell et al. 2014 ; Analogous to the postnatal occurrence of somatic mutations, we previously demonstrated a 84 similar phenomenon, termed selfish spermatogonial selection, that occurs in the testes of 85 adult men as they age. However, because the testis contains germ cells that, upon 86 fertilization, will carry the genetic information across generations, this process has important 87 reproductive implications, being associated with an increased prevalence of pathogenic 88 are observed up to 1000-fold more frequently in offspring (Goriely and Wilkie 2012) . These 92 pathogenic mutations, which cause developmental disorders that show an extreme paternal 93 bias in origin and an epidemiological paternal age effect (collectively referred to as PAE 94 disorders; for example achondroplasia, Apert, Costello and Noonan syndromes, multiple 95 endocrine neoplasia type 2a/b), are identical (or allelic) to oncogenic driver mutations in 96 tumors (Goriely and Wilkie 2012) . We proposed that although the mutational events arise at 97 low background rates in male germ cells, selfish mutations confer a selective advantage to 98 spermatogonia leading to their clonal expansion, which results in increased apparent 99 mutation levels in sperm over time (Goriely and Wilkie 2012; Maher et al. 2014) . 100 101 Three methods have previously been used to detect selfish mutations in the male germline, 102 each of which has been limited in their ability to evaluate the process at scale: (1) 103 quantification in sperm, (2) quantification in testis biopsies and (3) direct identification in 104 seminiferous tubules. Detecting selfish mutations in sperm, in which individual mutations are 105 present at levels ranging from 10 -3 to <10 -6 , requires ultra-sensitive techniques that have 106 limited quantitative analysis to small regions of 1-6 nucleotides across five locations in FGFR2 107 Table 1 ). 109
To circumvent the technical challenges caused by mutational dilution within an entire 110 ejaculate, mutations may alternatively be identified following systematic dissection and 111 sequencing of DNA extracted from discrete testicular biopsies. The germ cells (from diploid 112 spermatogonia to haploid spermatozoa) are located in long (up to ~80 cm) highly convoluted 113 and tightly packed seminiferous tubules, comprising ~300-500 per testis (Glass 2005) . As 114 clonally expanding mutant spermatogonia are physically restricted to the tubules in which 115 they arise, their geographical distribution within the testis is confined to specific regions: the 116 existence of such localized foci has been demonstrated for selfish mutations in four genes 117 Table 1 ). However this approach is limited both by the 125 need to source fixed testis samples with good tissue morphology and DNA preservation, and 126 by the high threshold required for successful immunohistochemical detection (Maher et al. 127 2016a; Maher et al. 2016b) . 128 the extent of the genomic target that could feasibly be analyzed in a single experiment, we 137 exploited approach (2) above. By combining systematic dissection of 276 testicular biopsies 138 from 5 individuals with massively parallel simplex PCR and ultra-deep sequencing (~16,000x) 139 of mutational hotspots in 67 genes, we present the most comprehensive survey of mutations 140 clonally enriched in the human testis to date. We describe the identification of 61 distinct 141 variants across 15 genes with variant allele frequencies (VAF) as low as 0.06%, including 51 142 mutations and 6 novel genes with strong support for association with the process of selfish 143 spermatogonial selection. 144
145

RESULTS 146
To perform a discovery screen and identify novel mutations and genes under selection in the 147 male germline, we systematically biopsied human testes following the experimental design Methods for criteria used to include loci in screen), amplified using massively parallel simplex 153 PCR (RainDance Thunderstorm). To detect low level mosaicism (~0.1-3.0%), the background 154 at each genomic location was independently estimated for all 431 (of 500) amplicons (in 67 155 of 71 genes) that passed quality control ( Supplementary Table 2 ). After normalization, a 156 statistical model was applied to call outlier non-consensus variants at each genomic position 157 (within each amplicon): a minimum threshold of 10 variant reads and median coverage of > 158 5,000x was implemented to reduce false positive calls. As a conservative prioritization 159 strategy, only variants with two or more independent calls were further studied, resulting in 160 a set of 374 variant calls located at 361 genomic locations (see Methods). Visualization and 161 manual curation of each of these calls identified 115 higher confidence candidate variants, 162 distributed at 105 genomic positions across 165 biopsies (Supplementary Figure 1 and 163 Supplementary Table 3) . 164
165
As calling variants at low levels (<1%) is subject to PCR artefacts and sequencing errors 166 for further variant prioritization. We reasoned that variants called independently in 168 overlapping amplicons or in sample replicates (12 biopsies were amplified and sequenced in 169 duplicate) were least likely to be artefactual (Tier 1 variants, Table 1 ). 18 of the 40 Tier 1 170 variants (with VAF ranging from 0.10% to 2.63%) were re-screened by PCR or using single 171 molecule molecular inversion probes (smMIPs) and ultra-deep MiSeq sequencing (~30,000x). 172
Seventeen of the 18 (94%) variants were validated, suggesting the great majority of Tier 1 173 variants are true positive calls ( were sequenced in duplicate ( Supplementary Table 4 ): hence, we next investigated variants 193 that were called in single amplicons in two or more biopsies, at VAF of ≥0.2% in at least one 194 biopsy (Tier 2). Twenty-six Tier 2 variants were identified, 18 (69%) of which were validated 195 upon resequencing (Table 1 , Supplementary Table 3 ). Notably, all (14/14) of the known 196 pathogenic variants were validated, but only four of the twelve variants without prior disease 197 association were true positives. In biopsy 4D25, PTPN11 c.1504T>A (p.Ser502Thr -Noonan 198 syndrome) was called as a single nucleotide variant but on validation it was identified as a 199 double nucleotide substitution c.1504_1505delTCinsAA (p.Ser502Lys). Next, 29 variants with 200 a VAF of 0.1 -<0.2% called in a single amplicon in two or more biopsies (Tier 3) were identified. 201
Only 4 of the 22 (18%) resequenced Tier 3 variants were validated, suggesting that in this 202 lower frequency range, the majority of calls are artefactual (Table 1 , Supplementary Table 3) . 203
Owing to the low validation rate of variants with VAFs of 0.1 -<0.2%, none of the remaining 204 20 calls that exhibited VAF <0.1% (Tier 4) variants were re-screened for validation 205 ( Supplementary Table 3 ). 206
207
Overall we identified 61 distinct variants that we classified as independently validated, 208 present in 15 of the 67 genes that passed quality control and were analyzed in the experiment. 209
Based on the identification of the same variant in testes sourced from different men, we 210 conclude that at least 72 independent mutational events (clones) could be distinguished 211 across the five testes (Table 1, Figure 1 
, Supplementary Figs 2-3). Two variants (FGFR2 212
c.755C>G (p.Ser252Trp) (#7) and KRAS c.35G>C (p.Gly12Ala) (#19)) occurred in three testes 213 and seven in two testes (Figure 1; Supplementary Fig 2) . Strikingly, these variants are all either 214 recurrent mutations causative of congenital skeletal disorders, or known hotspots in cancer 215 (COSMIC) that may be associated with lethal or as yet undescribed congenital disorders ( Table  216 1). Figure 2 details all validated variants for the two genes most highly represented in this list, 217 FGFR2 and PTPN11 (15 independent mutational events responsible for 10 distinct variants in 218 FGFR2 (encoding nine pathogenic protein changes); and 22 independent mutational events 219 of 20 distinct variants in PTPN11). Their relative locations on the respective protein products 220
shows striking overlap with mutational hotspots previously associated with developmental 221 disorders and cancer. The corollary is that our observations of these mutations in testes are 222 likely to be relevant to the biological origins of the cognate diseases. Similar plots for 13 other 223 genes with validated variants are presented in Supplementary Figure 3 . Next, using the geographical register of the multiple biopsies, the spatial distribution of each 266 variant across the testicular biopsies was investigated (Figure 1, Supplementary Figure 2 disease association] ( Supplementary Figures 2 and 4) . 293
Testis 5J (34 years)
294
In contrast to selfish mutations that arise in adult spermatogonia and are therefore restricted 295 to the seminiferous tubules in which they arise, 'classical' post-zygotic mosaic mutations 296 occurring in embryonic primordial germ cells, before the formation of the seminiferous 297 tubules, are expected to have a wider distribution in one or both testes. We found one To explore the relationship between mutational events identified using RainDance technology 309 (which inherently involves destruction of the tissue structure of the testis) and the occurrence 310 of mutations in individual seminiferous tubules, we exploited the availability of adjacent FFPE 311 material for two of the testes. In Tes1D, our deep-screening strategy identified a FGFR2 312 c.1024T>A (p.Cys342Ser) variant at VAFs ranging from 0.26% to 2.95% in seven contiguous 313 biopsies, suggestive of a clonal event tracking a single seminiferous tubule across the testis 314 ( Figures 1 and 2, variant #44 ). For this testis, we had previously studied the adjacent FFPE 315 (Table 1) . 354
355
Several observations support the notion that the mutations identified are strongly enriched 356 for clonal events that are promoted by positive selection of mutant stem cells via the 357 phenomenon of selfish spermatogonial selection. Out of the 61 validated variants (Table 1) , 358 43 are located in five (FGFR2, FGFR3, KRAS, PTPN11, RET) of the six genes associated with 359 strong prior experimental evidence for this process ( Supplementary Table 1 ). As detailed in 360 Table 1 seminiferous tubules, and in three cases this process could be directly validated at a cellular 368 level by visualizing the selfish expansion characterized by enhanced MAGEA4 staining in the 369 adjacent testis block (Figure 3 and (Maher et al. 2016a) ). The largest number of mutations 370 was observed for PTPN11 (encoding the SHP2 tyrosine phosphatase), in which we identified 371 20 different variants (across 33 biopsies) (Table 1 and Figure 2B ). We observed 12 distinct 372 variants located within the N-SH2 domain of SHP2, a region of the protein known to repress 373 the catalytic phosphatase domain in its wild-type state (Neel et al. 2003) , including each of 374 the possible nucleotide substitutions at PTPN11 c.215C encoding three distinct amino acids 375 (p.Ala72Asp, p.Ala72Gly and p.Ala72Val) that have been associated with Noonan syndrome 376 20 or oncogenesis. This wide mutational spectrum is consistent with epidemiological data that 377 concur that PTPN11-associated Noonan syndrome mutations have a high spontaneous birth 378 prevalence (~1/10,000 births) (Goriely and Wilkie 2012). We also identified two dinucleotide 379 substitutions in PTPN11: both the c.226_227delGAinsCT (p.Glu76Leu (#30)) and the Among the variants we identified, we observed a high proportion of strongly oncogenic 428 mutations with 23 of the 35 non-synonymous variants reported in COSMIC (v82) having never 429 been described as constitutional mutations (Table 1) . Strong gain-of-function mutations 430 would be more likely to promote efficient expansion of spermatogonial stem cells and result 431 in larger clones that are easier to detect. However, in order to be transmitted, the mutations 432 must be compatible with formation of functional sperm and with embryonic development. 433
We previously showed that tubules with spermatogonia harboring strongly oncogenic 434 variants are associated with reduced numbers of post-meiotic cells (Maher et al. 2016a ). This 435 would represent a mechanism by which the testis 'filters' the transmission of pathogenic 436 mutations across generations, although proof of this concept would require development of 437 ultra-sensitive assays to screen large numbers of sperm samples. It is noteworthy that despite 438 the relative abundance of strongly oncogenic mutations in the adult male germline, testicular 439 tumors originating from adult spermatogonia (spermatocytic tumors) are extremely rare, 440
with an incidence of ~1 per million men and are mostly benign in nature (Ghazarian et al. 0.6%), in keeping with the expectation that the prevalence and size of mutant clones increases 449 with time. It was however surprising that no variants were detected in Tes3D, given the 450 advanced age of the donor (87 years). Although it is possible that this individual may have had 451 a low propensity to accumulation of selfish mutations, a more likely explanation is that few 452 or no germ cells were present in this testis slice, either due to Sertoli-cell only syndrome or 453 due to age-related atrophy (Paniagua et al. 1987) . Unfortunately, as no tissue had been 454 preserved for histological analysis, we were unable to determine the status of 455 spermatogenesis in this sample. conservative custom statistical approach to determine the background error rate at each 463 position and to prioritize variants ( Supplementary Figure 1) . Although we confirmed variants 464 with a frequency as low as 0.06% using this approach, the majority (81.8%) of the prioritized 465 variants called in single amplicon at VAFs of 0.1-0.2% (Tier 3) were false positives. In the 466 twelve samples amplified and sequenced in duplicate, only 7 of 15 variants were called in 467 both replicates ( Supplementary Table 4 ). The best predictor of true positives was the 468 presence of a call in more than one amplicon (100% validation rate); for calls in single Table 2 ; Supplementary Fig  483   3E ). 484
485
In summary this work represents a new approach to studying DNMs directly in their tissue of 486 origin. By utilizing the clonal nature of mutations that leads to focal enrichment, we 487 circumvented the technical difficulties associated with calling DNMs in single sperm or the 488 poor DNA quality associated with immunopositive tubules from FFPE material. In a single 489 biopsy a whole population of de novo mutations can be assessed. Studying mutations within 490 the testis facilitates identification of mutations and pathways under positive selection in 491 spermatogonia but that may be incompatible with life, either by impairing gamete 492 differentiation and sperm production or by causing early embryonic lethality. Our approach 493 reveals the prevalence and geographical extent of clonal mutations in normal human testes, 494
suggesting that the ageing male germline is a repository for functionally significant, often 495 deleterious mutations. Based on an estimated total birth prevalence of DNMs causing 496 developmental disorders of 1 in 295 (DDD 2017), such PAE mutations may contribute 5-10% 497 of the total burden of pathological mutations, depending on paternal age. Investigating the 498 clonal nature of spontaneous testicular variants also provides insights into the regulation of 499 the poorly-studied human spermatogonial stem cell dynamics and how spontaneous 500 pathogenic mutations hijack homeostatic regulation in this tissue to increase their likelihood 501 of transmission to the next generation. 502 503 504 METHODS 505
Testis samples 506
Ethical approval was given for the use of human testicular tissue by the Oxfordshire Research 507
Ethics Committee A (C03.076: Receptor tyrosine kinases and germ cell development: 508 detection of mutations in normal testis, testicular tumors and sperm). Testes from five men 509 aged 34, 71, 83, 87 and 90 years were either commercially sourced or obtained locally from 510 research banks or post-mortems, with appropriate consent ( Supplementary Table 5 ). Each 511 testis was cut into slices ~3-5 mm thick and either stored frozen at -80°C or formalin-fixed. 512
After thawing slices of frozen testis, extraneous tissue (epididymis or tunica albuginea) was 513 removed and slices were further dissected into 21-36 biopsies ( Supplementary Table 5 ). 514
Biopsies were pulverized using a pestle and DNA extraction was performed using the Qiagen 515 in other pathways associated with spontaneous disorders that display narrow mutational 527 spectra suggestive of gain-of-function effects but lacking epidemiological data for paternal 528 age-effect, oncogenes commonly mutated in cancer, some of which are also associated with 529 germline disorders, and regions of 10 control genes. Details of all targeted regions and 530 primers used for amplification are provided in Supplementary Table 6 . To maximize the 531 number of different molecules amplified, massively parallel simplex PCR was performed using 532 the RainDance Thunderstorm target enrichment system following the manufacturer's 533 instructions. Briefly, for each sample, 6 µg of genomic DNA (gDNA) was sheared to an average 534 size of 3,000 bp (using a Covaris blue AFA miniTUBE) and purified using a minElute column 535 (Qiagen). One microliter (out of 20 µl) was run on a gel to verify that the gDNA had been 536 sheared to the correct size range and the remaining gDNA was quantified using a Qubit 
Sequence alignment and variant calling and prioritization 563
Low quality reads with more than 20 bases below Q20, read pairs with one or two short (<50 564 bp) reads and reads pairs with unmatched or mismatched sequences between the forward 565 and reverse primer pairs expected for each amplicon were removed. Reads passing QC (on 566 average 86% of reads) were aligned to the human genome (hg19) using BWA-MEM version 567 0.7.10 (Li 2014) with default parameter settings. Primer sequences were included in the 568 alignment but ignored during variant quantification. The Python library Pysam was used to 569 fetch reads mapped to each amplicon and mapped bases (indicated as letter "M") were 570 identified from the CIGAR string. Pileup was then performed for each amplicon 571
independently. Nine amplicons that did not map to the targeted genomic regions were 572 excluded from subsequent analyses ( Supplementary Table 2 ). Reads with more than 10 non-573 Following these normalization steps, variant calling was performed using a normal model to 594 test for an increase in non-consensus variant calls. Assuming that under the null hypothesis 595 the normalized variant quantification follows a normal distribution H0: P(gi) = N(c " , " % ) with 596 mean " and variance " , estimated using signals from all samples. We applied a one-sided z 597 test in R (pnorm(g, mean=mu0, sd=sigma2, lower.tail=FALSE). Non-consensus calls at each 598 genomic position across the 288 samples were tested independently in each amplicon that 599 passed QC. Variant prioritization was performed using a P-value cutoff of -log10P > 20, which 600 resulted in a total of 19,625 genomic positions with at least one non-reference call. 601
602
As samples or amplicons with an excessive number of variants were more likely to represent 603 technical artefacts, these outliers were identified using a Chi Square (χ 2 ) test, where the 604 expected number of substitutions is defined as the median across all samples. Using a χ 2 605 threshold of -log10P > 3, seven amplicons and 185 sample-mutation combinations were 606 removed from further analysis. Notably, the majority of these were C>A (=G>T) variant calls 607 ( Supplementary Figure 4) , which represent a known mutational signature associated with 608 oxidative stress that likely arose during sample preparation (Arbeithuber et al. 2016; Chen et 609 al. 2017). Further filtering was performed to remove potential sources of artefacts: calls 610 positioned 1 base from the amplification primer 3'-end were excluded; calls with a maximum 611 VAF of ≥3% were excluded to avoid calling SNPs and to eliminate gross alignment errors or 612 calling of non-consensus variants resulting from homologous genomic regions or pseudogene 613 amplification; positions with a median depth coverage below 5,000x across all samples were 614 excluded (this removed a 53 further amplicons (10.6%) from the analysis; Supplementary 615 Table 2 ). This resulted in a total of 5729 calls (5659 distinct variants) at 5421 positions, the 616 majority (90.2%) of which were made in a single amplicon and sample. As singleton calls were 617 more likely to represent PCR or sequencing artefacts, we further prioritized calls made in two 618 or more samples and/or present in overlapping amplicons. To exclude potential batch effects, 619 variants were excluded if all calls were made from a single library and the number of calls was 620 >3. This strategy identified 374 variants at 361 genomic positions. VAFs across all samples at 621 each of the 361 genomic positions were plotted and manually inspected for sequencing 622 library preparation or batch effects; raw sequencing reads from calls with suspected sequence 623 misalignment were visualized in Integrative Genomics Viewer (IGV) (Robinson et al. 2011) . 624
Variant calls showing evidence of library-specific batch or sequence misalignment effects 625 were excluded from further analysis. Variants in PTPN11 that matched bases at homologous 626 positions in one of its four pseudogenes were also excluded. The remaining 115 variants at 627 105 genomic positions were annotated with ANNOVAR version 2015Jun17 (Wang et al. 2010) . 628 629
Variant validation 630
DNA from at least one putative-positive biopsy sample and at least 8 control samples 631 (unrelated blood gDNA and gDNA from other testicular biopsies) was screened by PCR or 632 single molecule molecular inversion probes (smMIPs) (primer and smMIP details in 633 Supplementary Table 6 ) and sequenced using Illumina MiSeq 300v2 (PCR) or 150v3 (smMIP) 634 kits (further details in Supplementary Methods). Demultiplexed reads were aligned to the 635 human genome (hg19) using BWA-MEM version 0.7.12 (Li 2014) . Summary tables of the calls 636 across the aligned target region for PCR and smMIPs were generated using SAMtools mpileup 637 and a custom script (Amplimap -see Supplementary Methods), respectively. A base call was 638 only considered if its mapping quality was ≥Q20 and phred score ≥Q30. Validated variants 639
were annotated according to the following transcripts -APC: NM_001127510, AKT3: 640 
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